[go: up one dir, main page]

WO1990003164A3 - Formulations pharmaceutiques - Google Patents

Formulations pharmaceutiques Download PDF

Info

Publication number
WO1990003164A3
WO1990003164A3 PCT/GB1989/001161 GB8901161W WO9003164A3 WO 1990003164 A3 WO1990003164 A3 WO 1990003164A3 GB 8901161 W GB8901161 W GB 8901161W WO 9003164 A3 WO9003164 A3 WO 9003164A3
Authority
WO
WIPO (PCT)
Prior art keywords
biologically active
active material
chylomicra
formulations
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1989/001161
Other languages
English (en)
Other versions
WO1990003164A2 (fr
Inventor
Young W Cho
Michael John Flynn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Patralan Ltd
Original Assignee
Patralan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patralan Ltd filed Critical Patralan Ltd
Priority to BG89877A priority Critical patent/BG60849B1/bg
Publication of WO1990003164A2 publication Critical patent/WO1990003164A2/fr
Publication of WO1990003164A3 publication Critical patent/WO1990003164A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Des formulations, administrables par voie orale ou rectale, d'une substance biologiquement active comprennent une micro-émulsion aqueuse. La phase hydrophile de cette micro-émulsion comprend la substance biologiquement active et la phase hydrophobe renferme de la chylomicra ou une substance susceptible de former de la chylomicra dans la muqueuse intestinale après administration. La substance biologiquement active peut être n'importe laquelle parmi une large gamme de substances comprenant l'insuline, la calcitonine et la somatotrophine ou hormone de croissance. Les formulations décrites conviennent particulièrement à l'administration orale d'insuline dans le traitement du diabète.
PCT/GB1989/001161 1988-09-29 1989-09-29 Formulations pharmaceutiques Ceased WO1990003164A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG89877A BG60849B1 (bg) 1988-09-29 1989-09-29 Фармацевтична форма и метод за получаването й

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8822857.2 1988-09-29
GB888822857A GB8822857D0 (en) 1988-09-29 1988-09-29 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
WO1990003164A2 WO1990003164A2 (fr) 1990-04-05
WO1990003164A3 true WO1990003164A3 (fr) 1990-06-14

Family

ID=10644447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1989/001161 Ceased WO1990003164A2 (fr) 1988-09-29 1989-09-29 Formulations pharmaceutiques

Country Status (28)

Country Link
US (1) US5656289A (fr)
EP (1) EP0366277B1 (fr)
JP (1) JP2927835B2 (fr)
KR (1) KR0139641B1 (fr)
AR (1) AR243375A1 (fr)
AT (1) ATE98480T1 (fr)
AU (2) AU4341789A (fr)
BG (1) BG60849B1 (fr)
CA (1) CA1339814C (fr)
CZ (1) CZ285237B6 (fr)
DD (1) DD300405A5 (fr)
DE (1) DE68911473T2 (fr)
DK (1) DK481989A (fr)
ES (1) ES2060785T3 (fr)
FI (1) FI98196C (fr)
GB (1) GB8822857D0 (fr)
HK (1) HK85596A (fr)
HU (2) HUT54033A (fr)
IE (1) IE63543B1 (fr)
MX (1) MX17752A (fr)
NO (1) NO300199B1 (fr)
NZ (1) NZ230838A (fr)
PL (1) PL163635B1 (fr)
PT (1) PT91850B (fr)
RO (1) RO108219B1 (fr)
RU (1) RU2122403C1 (fr)
WO (1) WO1990003164A2 (fr)
ZA (1) ZA897437B (fr)

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541155A (en) 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5578323A (en) * 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5629020A (en) 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5451410A (en) * 1993-04-22 1995-09-19 Emisphere Technologies, Inc. Modified amino acids for encapsulating active agents
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5443841A (en) 1992-06-15 1995-08-22 Emisphere Technologies, Inc. Proteinoid microspheres and methods for preparation and use thereof
US5693338A (en) 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel
US5614219A (en) * 1991-12-05 1997-03-25 Alfatec-Pharma Gmbh Oral administration form for peptide pharmaceutical substances, in particular insulin
CA2125400A1 (fr) * 1991-12-18 1993-06-24 Gordon L. Amidon Proteines ou substances peptidiques, presentes dans des compositions pharmaceutiques pour proteger les peptides bioactifs contre l'inactivation enzymatique
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5811127A (en) 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US6153592A (en) * 1992-11-09 2000-11-28 Port Systems, Llc Enhancing the bioavailability of proteolytically labile therapeutic agents
US5401516A (en) 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
ATE223231T1 (de) * 1993-04-19 2002-09-15 Inst Advanced Skin Res Inc Mikroemulsionszubereitung enthaltend eine schwer absorbierbare substanz
US5958457A (en) 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5709861A (en) 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
ATE204467T1 (de) 1993-04-22 2001-09-15 Emisphere Tech Inc Orale darreichungsform
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
AU7706494A (en) * 1993-09-29 1995-04-18 Technobiochip Protein thin films and compositions for use in their preparation
WO1995012385A1 (fr) * 1993-11-03 1995-05-11 Isotech Medical, Inc. Compositions pharmaceutiques microparticulaires sous forme micellaire
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
GB9424902D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Solubilisation Aids
DE69611287T2 (de) * 1995-02-06 2001-08-09 Elan Pharma International Ltd., Shannon Formulierungen von verbindungen als nanopartikel dispergiert in verdaubaren ölen oder fettsäuren
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US5989539A (en) 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6090958A (en) 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO1997036480A1 (fr) 1996-03-29 1997-10-09 Emisphere Technologies, Inc. Composes et compositions d'apport de principes actifs
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5965121A (en) 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
BR9604880A (pt) 1995-03-31 1998-05-19 Emisphere Tech Inc Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
US5820881A (en) 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
US5824345A (en) 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5667806A (en) 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
WO1997010197A1 (fr) 1995-09-11 1997-03-20 Emisphere Technologies, Inc. PROCEDE POUR PREPARER DES DERIVES D'ACIDES φ-AMINOALCANOIQUES A PARTIR DE CYCLOALCANONES
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
AU716747B2 (en) * 1996-02-12 2000-03-02 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
CA2258264A1 (fr) 1996-06-14 1997-12-18 Emisphere Technologies, Inc. Parfums microencapsules et leur procede de production
CA2259179C (fr) * 1996-07-03 2008-09-23 University Of Pittsburgh Formulations d'emulsions pour des agents actifs hydrophiles
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6150164A (en) * 1996-09-30 2000-11-21 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
ES2130056B1 (es) * 1997-01-16 2000-02-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad oral de drogas de dificil absorcion.
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5876710A (en) 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
EP1080720A4 (fr) * 1998-03-05 2002-06-05 Nippon Shinyaku Co Ltd Emulsions huileuses destinees a etre administrees par inhalation
JP3785932B2 (ja) * 1998-05-25 2006-06-14 日本新薬株式会社 核酸含有複合体製剤の製造方法
CN1245955C (zh) 1998-05-29 2006-03-22 斯凯伊药品加拿大公司 热保护微粒组合物及其最终蒸汽灭菌的方法
US6660277B1 (en) 1998-06-19 2003-12-09 Avon Products, Inc. Gel matrix non-emulsion composition containing two clay gels
JP4815053B2 (ja) * 1998-08-13 2011-11-16 シーマ・ラブス、インコーポレイテッド 経口投与の固形投与形態物としてのマイクロエマルション
WO2000010531A1 (fr) 1998-08-19 2000-03-02 Rtp Pharma Inc. Dispersions aqueuses injectables de propofol
HK1042856B (zh) 1998-11-20 2007-07-27 Skyepharma Canada Inc. 可分散的磷脂稳定的微粒
DE19855819C2 (de) * 1998-12-03 2001-02-15 Roche Diagnostics Gmbh Stabilisierung von Cytokeratin enthaltenden Kalibratoren
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
ATE401908T1 (de) 1999-04-09 2008-08-15 Ortho Mcneil Pharm Inc Pharmazeutische zusammensetzungen von erythropoietin
US6176849B1 (en) * 1999-05-21 2001-01-23 Scimed Life Systems, Inc. Hydrophilic lubricity coating for medical devices comprising a hydrophobic top coat
US6610035B2 (en) 1999-05-21 2003-08-26 Scimed Life Systems, Inc. Hydrophilic lubricity coating for medical devices comprising a hybrid top coat
US6982281B1 (en) * 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
AU730929B2 (en) * 1999-07-06 2001-03-22 Nestec S.A. Composition and method for prolonging the useful life of enteral feeding tubes
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US6417237B1 (en) * 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
US6692771B2 (en) 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
RU2197986C2 (ru) * 2001-03-23 2003-02-10 Волчек Игорь Анатольевич Иммуномодулирующее средство неинъекционного применения
US6951655B2 (en) * 2001-10-11 2005-10-04 Imi Biomed, Inc. Pro-micelle pharmaceutical compositions
DE10158447B4 (de) * 2001-11-30 2005-02-10 Aquanova German Solubilisate Technologies (Agt) Gmbh Ascorbinsäure-Solubilisat
ITMI20012694A1 (it) * 2001-12-19 2003-06-19 Remedia S R L Composizione farmaceutica comprendente una microemulsione doppia olio/acqua/olio incorporata in un supporto solido
GB0207092D0 (en) * 2002-03-26 2002-05-08 Sod Conseils Rech Applic Stable pharmaceutical composition containing factor VIII
SI21258A (sl) * 2002-07-17 2004-02-29 LEK farmacevtska dru�ba d.d. Stabilni farmacevtski pripravek, ki vsebuje eritropoietin in poloksamerni poliol
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
EP1537880A4 (fr) * 2002-09-11 2009-07-01 Takeda Pharmaceutical Preparation a liberation prolongee
FR2851918B1 (fr) * 2003-03-06 2006-06-16 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
EP1537876A1 (fr) * 2003-12-01 2005-06-08 BioGeneriX AG Formulation d'une solution d'érythropoiétine
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
EP1742663A2 (fr) 2004-04-15 2007-01-17 Chiasma, Ltd. Compositions capables de faciliter la penetration a travers une barriere biologique
WO2005115340A1 (fr) * 2004-05-19 2005-12-08 Glatt Air Techniques, Inc. Granules contenant des microgranules et procede de preparation de ces granules
EP1652513A1 (fr) * 2004-11-02 2006-05-03 Denderah Pharm Sa Micelles inversées basés sur des stérols et des acylglycerols and leur utilisation thérapeutique
US20070071779A1 (en) * 2005-09-26 2007-03-29 Leggit Ingenuity, Llc Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof
RU2315619C2 (ru) * 2006-02-07 2008-01-27 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Суппозитории с интерфероном
WO2007127787A2 (fr) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Lymphocytes t cd4+ de régulation spécifique auto-antigénique de l'insuline
US9918934B2 (en) * 2006-12-12 2018-03-20 Edgar Joel Acosta-Zara Linker-based lecithin microemulsion delivery vehicles
ES2402671T3 (es) * 2007-04-24 2013-05-07 Generale Biscuit Proceso de pulverización de una capa que contiene grasa y azúcar en una superficie de un producto comestible
EP2200613B1 (fr) 2007-09-21 2018-09-05 The Johns Hopkins University Dérivés de phénazine et leurs utilisations
JP5156458B2 (ja) * 2008-03-31 2013-03-06 理研ビタミン株式会社 ソフトカプセル充填用液状組成物
KR101503474B1 (ko) * 2007-09-27 2015-03-18 리켄 비타민 가부시키가이샤 연질 캅셀 충전용 액상 조성물
CA2963659C (fr) 2008-09-17 2020-06-23 Chiasma Inc. Utilisation de compositions orales d'octreotride
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
RU2414150C2 (ru) * 2009-02-02 2011-03-20 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Способ коррекции общего уровня трипсин-ингибиторной активности сыворотки крови с помощью соевого печенья, обогащенного активным соевым ингибитором
US9309378B2 (en) 2009-06-19 2016-04-12 Exacto, Inc. Emulsion compositions comprising polyacrylamide copolymer and ethylene oxide—propylene oxide copolymer
US9428630B2 (en) 2009-06-19 2016-08-30 Exacto, Inc. Water-in-oil polyacrylamide-based microemulsions and related methods
US9307758B2 (en) * 2009-06-19 2016-04-12 Exacto, Inc. Polyacrylamide based agricultural compositions
CN101756900B (zh) * 2010-02-25 2012-05-30 谢恬 一种榄香烯微乳
JP5406110B2 (ja) * 2010-04-20 2014-02-05 日東電工株式会社 半導体ウエハ加工用粘着シート
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
ES2981705T3 (es) * 2013-12-11 2024-10-10 Health Ever Biotech Co Ltd Composiciones farmacéuticas de carotenoides
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
FI3253401T3 (fi) 2015-02-03 2025-07-09 Amryt Endo Inc Akromegallian hoitaminen suun kautta annettavalla oktreotidilla
WO2016205423A2 (fr) 2015-06-15 2016-12-22 Lipocine Inc. Composition et méthode pour l'administration orale de promédicaments androgènes
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Composition pharmaceutique d'hormone stéroïde
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
GB201808563D0 (en) 2018-05-24 2018-07-11 Univ Manchester Treatments
GB201808564D0 (en) 2018-05-24 2018-07-11 Douglas Pharmaceuticals Ltd Treatments
WO2020011896A1 (fr) * 2018-07-10 2020-01-16 Universidade De Santiago De Compostela Système lipidique nanostructuré
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease
BR112021017773A2 (pt) 2019-03-14 2021-11-23 Exacto Inc Composição que compreende uma microemulsão de poliacrilamida e método que utiliza a dita composição para o gerenciamento de pragas de cultura
GB201907305D0 (en) 2019-05-23 2019-07-10 Douglas Pharmaceuticals Ltd Treatment of conditions
DE102019211195A1 (de) * 2019-07-26 2021-01-28 Add Advanced Drug Delivery Technologies Ltd. Verfahren und Vorrichtung zur Herstellung eines im Wesentlichen im wässrigen Milieu lösbaren Cannabinoid-Granulats
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CA3207576A1 (fr) * 2021-02-08 2022-08-11 Tyler White Vitamine c a liberation prolongee et sa fabrication
KR20240018456A (ko) * 2021-06-06 2024-02-13 스타트온 테라퓨틱스, 인크. 치료 유효량의 레날리도미드 및 다른 면역조정제의 투여를 위한 경피 약물 전달 시스템
US20240366731A1 (en) 2021-08-12 2024-11-07 Celagenex Research (India) Pvt. Ltd. Oral algal oil based gastro-intestinal tract permeable peptide composition

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
FR2455458A1 (fr) * 1979-05-02 1980-11-28 Kureha Chemical Ind Co Ltd Liposomes contenant une substance active, notamment un principe actif de medicament
GB2085729A (en) * 1980-10-17 1982-05-06 Dainippon Pharmaceutical Co Pharmaceutical composition for oral administration containing coagulation factor VIII
EP0140085A2 (fr) * 1983-09-12 1985-05-08 Fujisawa Pharmaceutical Co., Ltd. Préparation à base de vésicules lipidiques contenant un médicament et procédé de leur fabrication
US4536324A (en) * 1982-07-19 1985-08-20 Lion Corporation Nonionic surfactant type vesicle dispersion
FR2581543A1 (fr) * 1985-05-09 1986-11-14 Tressens Dominique Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale
EP0277776A2 (fr) * 1987-02-02 1988-08-10 The University Of Tennessee Research Corporation Liposomes à noyaux solides
WO1988006881A1 (fr) * 1987-03-13 1988-09-22 Micro-Pak, Inc. Procede de production de vesicules multilamellaires a volume aqueux eleve
WO1989000812A1 (fr) * 1987-07-28 1989-02-09 Micro-Pak, Inc. Procede de fabrication de vesicules de lipides unilamellaires
JPH06172721A (ja) * 1992-09-03 1994-06-21 Hitachi Kasei Polymer Kk 研磨材固定用テープ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165385A (en) * 1973-05-29 1979-08-21 Dianis Creations, Inc. Water-in-oil emulsion for skin moisturizing
JPS5517328A (en) * 1978-07-21 1980-02-06 Tanabe Seiyaku Co Ltd Insulin-containing emulsion and its preparation
JPS5772920A (en) * 1980-10-27 1982-05-07 Toyama Chem Co Ltd Carcinostatic agent containing blood plasma or blood serumal lipoprotein
JPS5821622A (ja) * 1981-07-28 1983-02-08 Kowa Co 糖尿病治療用薬剤
JPS60155109A (ja) * 1984-01-23 1985-08-15 Terumo Corp リポソ−ム製剤
JPS6172721A (ja) * 1984-09-19 1986-04-14 Daigo Eiyou Kagaku Kk インシユリン含有リポゾ−ム
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
FR2455458A1 (fr) * 1979-05-02 1980-11-28 Kureha Chemical Ind Co Ltd Liposomes contenant une substance active, notamment un principe actif de medicament
GB2085729A (en) * 1980-10-17 1982-05-06 Dainippon Pharmaceutical Co Pharmaceutical composition for oral administration containing coagulation factor VIII
US4536324A (en) * 1982-07-19 1985-08-20 Lion Corporation Nonionic surfactant type vesicle dispersion
EP0140085A2 (fr) * 1983-09-12 1985-05-08 Fujisawa Pharmaceutical Co., Ltd. Préparation à base de vésicules lipidiques contenant un médicament et procédé de leur fabrication
FR2581543A1 (fr) * 1985-05-09 1986-11-14 Tressens Dominique Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale
EP0277776A2 (fr) * 1987-02-02 1988-08-10 The University Of Tennessee Research Corporation Liposomes à noyaux solides
WO1988006881A1 (fr) * 1987-03-13 1988-09-22 Micro-Pak, Inc. Procede de production de vesicules multilamellaires a volume aqueux eleve
WO1989000812A1 (fr) * 1987-07-28 1989-02-09 Micro-Pak, Inc. Procede de fabrication de vesicules de lipides unilamellaires
JPH06172721A (ja) * 1992-09-03 1994-06-21 Hitachi Kasei Polymer Kk 研磨材固定用テープ

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN, Volume 10, No. 239 (C-367) (2295), 19 August 1986; & JP-A-6172721 (Daigo Eiyou Kagaku K.K.) 14 April 1986 *
PATENT ABSTRACTS OF JAPAN, Volume 6, No. 154 (C-119) (1032), 14 August 1982; & JP-A-5772920 (Toyama Kagaku Kogyo K.K.) 7 May 1982 *
PATENT ABSTRACTS OF JAPAN, Volume 7, No. 97 (C-163) (1242), 23 April 1983; & JP-A-5821622 (Kouwa K.K.) 8 February 1983 *

Also Published As

Publication number Publication date
HK85596A (en) 1996-05-24
FI894637A0 (fi) 1989-09-29
AR243375A1 (es) 1993-08-31
DE68911473D1 (de) 1994-01-27
GB8822857D0 (en) 1988-11-02
PT91850B (pt) 1996-08-30
IE63543B1 (en) 1995-05-17
BG89877A (bg) 1993-12-24
FI98196C (fi) 1997-05-12
AU4243289A (en) 1990-04-05
DD300405A5 (de) 1992-06-11
HUT54033A (en) 1991-01-28
HU211633A9 (en) 1995-12-28
JPH02218609A (ja) 1990-08-31
NO893896D0 (no) 1989-09-29
RU2122403C1 (ru) 1998-11-27
MX17752A (es) 1993-12-01
BG60849B1 (bg) 1996-05-31
RO108219B1 (ro) 1994-03-31
CZ285237B6 (cs) 1999-06-16
ATE98480T1 (de) 1994-01-15
US5656289A (en) 1997-08-12
EP0366277A2 (fr) 1990-05-02
NO893896L (no) 1990-03-30
ES2060785T3 (es) 1994-12-01
AU4341789A (en) 1990-04-18
EP0366277A3 (en) 1990-11-28
DK481989D0 (da) 1989-09-29
PT91850A (pt) 1990-03-30
FI894637L (fi) 1990-03-30
CZ554889A3 (cs) 1999-01-13
KR900004327A (ko) 1990-04-12
IE893118L (en) 1990-03-29
NZ230838A (en) 1991-03-26
EP0366277B1 (fr) 1993-12-15
JP2927835B2 (ja) 1999-07-28
AU625498B2 (en) 1992-07-16
WO1990003164A2 (fr) 1990-04-05
DE68911473T2 (de) 1994-05-05
KR0139641B1 (ko) 1998-06-01
CA1339814C (fr) 1998-04-14
FI98196B (fi) 1997-01-31
PL163635B1 (pl) 1994-04-29
DK481989A (da) 1990-03-30
ZA897437B (en) 1991-06-26
NO300199B1 (no) 1997-04-28

Similar Documents

Publication Publication Date Title
WO1990003164A3 (fr) Formulations pharmaceutiques
HU9203093D0 (en) Medical preparative
IE871584L (en) Sustained release capsule.
CA2038672A1 (fr) Forme posologique pour l'administration d'un medicament au niveau intestinal
AU2581888A (en) Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations
LV10196A (lv) Olbaltumviela biologiski aktivais hormons olbaltumvielas iegusanas panemiens farmaceitisks preparats
ATE201989T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe
IL87055A0 (en) Topical pharmaceutical compositions
CA2258095A1 (fr) Compositions contenant de la tetrahydrolipstatine
AU5620598A (en) Pharmaceutical preparations of glutathione and methods of administration thereof
WO1998000115A3 (fr) Forme stable de medicament pour administration orale et son procede de fabrication
DE69213800D1 (de) Oral anzuwendende magensaftstabile Arzneimittel mit gesteuerter Wirkstoffabgabe enthaltend Gallensäuren und deren Salze
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
ZA968715B (en) Stable pharmaceutical forms of administration containing parathyroid hormone.
EP0177342A3 (fr) Formulations orales de protéines thérapeutiques
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
ES2058988T3 (es) Preparacion de medicamentos para el tratamiento sistemico de peces ornamentales y utiles.
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
EP0271151A3 (fr) Formes de dosage de l'azumolène
IE43089L (en) Biologically active polypeptides
EP0649660A3 (fr) Compositions pharmaceutiques pour l'administration parentérale, entérale et dermale d'agents actifs pratiquement insolubles, et procédé pour leur fabrication.
AU1984988A (en) Hexapeptide and pharmaceutical preparation based thereon for curing erosive-ulcerous injuries to the digestive tract
Familiari et al. Short-term ranitidine(ranidil) and cimetidine therapy of duodenal ulcer. A comparative endoscopic investigation.
JPS5462327A (en) Remedy for dna virus infectious disease

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR CH DE DK FI GB HU JP KP KR LK LU MC MG MW NL NO RO SD SE SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BF BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR CH DE DK FI GB HU JP KP KR LK LU MC MG MW NL NO RO SD SE SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BF BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642